144 related articles for article (PubMed ID: 7475891)
1. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects.
Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gur RC; Wolf AP
Life Sci; 1995; 56(14):PL249-53. PubMed ID: 7475891
[TBL] [Abstract][Full Text] [Related]
2. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain.
Iyo M; Yamasaki T
Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):415-21. PubMed ID: 8475323
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5-HT2 receptor availability in chronic cocaine abusers.
Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gjedde A; Wolf AP
Life Sci; 1995 Mar; 56(16):PL299-303. PubMed ID: 8614247
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
6. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
[TBL] [Abstract][Full Text] [Related]
8. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
[TBL] [Abstract][Full Text] [Related]
9. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
[TBL] [Abstract][Full Text] [Related]
10. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
[TBL] [Abstract][Full Text] [Related]
11. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET.
Inoue M; Suhara T; Sudo Y; Okubo Y; Yasuno F; Kishimoto T; Yoshikawa K; Tanada S
Life Sci; 2001 Jul; 69(9):1079-84. PubMed ID: 11508650
[TBL] [Abstract][Full Text] [Related]
12. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
13. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
14. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
[TBL] [Abstract][Full Text] [Related]
16. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
[TBL] [Abstract][Full Text] [Related]
17. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
[TBL] [Abstract][Full Text] [Related]
18. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
Kaasinen V; Vilkman H; Hietala J; Någren K; Helenius H; Olsson H; Farde L; Rinne J
Neurobiol Aging; 2000; 21(5):683-8. PubMed ID: 11016537
[TBL] [Abstract][Full Text] [Related]
19. Age associated decrements in dopamine D2 receptors in thalamus and in temporal insula of human subjects.
Wang GJ; Volkow ND; Fowler JS; Logan J; Gur R; Netusil N; Hitzemann RJ; Pappas NS
Life Sci; 1996; 59(1):PL31-5. PubMed ID: 8684263
[TBL] [Abstract][Full Text] [Related]
20. Brain dopamine and obesity.
Wang GJ; Volkow ND; Logan J; Pappas NR; Wong CT; Zhu W; Netusil N; Fowler JS
Lancet; 2001 Feb; 357(9253):354-7. PubMed ID: 11210998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
